Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ProNAi Therapeutics Inc | 2,433,577 | reported | 21 Jul 2015 | tx 8+2,438,270−2,109,299 |
| VYNE Therapeutics Inc. | 486,695 | reported | 29 Jan 2018 | tx 10+4,011,236−10,026,934 |
| BIOFORM MEDICAL INC | 412,588 | reported | 09 Nov 2007 | tx 15+1,851,542−1,851,542 |
| Biohaven Pharmaceutical Holding Co Ltd. | 18,000 | reported | 01 May 2018 | tx 5+2,067,545−1,506,818 |
| Biodel Inc | 10,000 | reported | 28 Feb 2008 | tx 4+1,088,933−1,210,933 |
| KalVista Pharmaceuticals, Inc. | 10,000 | reported | 26 Sept 2023 | tx 52+9,788,283−6,420,126 |
| Aclaris Therapeutics, Inc. | 6,632 | reported | 29 Jun 2016 | tx 7+3,908,175−11,846,087 |
| SOLENO THERAPEUTICS INC | 0 | reported | 18 Nov 2014 | tx 47+5,687,041−11,818,669.85 |
2 purchases reported after at least 12 months of silence — most recent on 30 Oct 2020.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Sept 2023 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 11 Sept 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,000 | 6.71 USD | |
| 11 Sept 2023 | SALE | KalVista Pharmaceuticals, Inc. | 18,000 | 10.50 USD | |
| 11 Sept 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 12,000 | 7.88 USD | |
| 11 Sept 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 11 Sept 2023 | EXERCISE | KalVista Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 13 Oct 2022 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 30 Sept 2021 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 30 Oct 2020 | PURCHASE | KalVista Pharmaceuticals, Inc. | 47,431 | 17.34 USD | first after silence |
| 30 Oct 2020 | PURCHASE | KalVista Pharmaceuticals, Inc. | 68,255 | 17.17 USD | |
| 01 Oct 2020 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7,000 | 0.00 USD | deriv |
| 02 Oct 2019 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7,000 | 0.00 USD | deriv |
| 26 Jul 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 4,558 | 16.83 USD | |
| 29 Jul 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 24,730 | 17.13 USD | |
| 29 Jul 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 5,137 | 17.13 USD | |
| 26 Jul 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 21,942 | 16.83 USD | |
| 17 Jul 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 1,060 | 16.97 USD | |
| 17 Jul 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 220 | 16.93 USD | |
| 19 Jul 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 49,680 | 17.84 USD | |
| 19 Jul 2019 | PURCHASE | KalVista Pharmaceuticals, Inc. | 10,320 | 17.68 USD | |
| 03 Oct 2018 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 7,000 | 0.00 USD | deriv |
| 10 Sept 2018 | PURCHASE | KalVista Pharmaceuticals, Inc. | 1,058,824 | 17.00 USD | |
| 01 May 2018 | GRANT_AWARD | Biohaven Pharmaceutical Holding Co Ltd. | 18,000 | 0.00 USD | deriv |
| 14 Mar 2018 | GRANT_AWARD | Biohaven Pharmaceutical Holding Co Ltd. | 72,727 | 27.50 USD | |
| 25 Jan 2018 | PURCHASE | VYNE Therapeutics Inc. | 35,686 | 17.00 USD |